Funded Tech Companies
EpiVax Oncology
Headquartered in Providence, EpiVax Oncology has funding from Morningside Group, NextWaveBio and Horatio Ventures NYC.
Company Overview
Company Name
EpiVax Oncology
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
188 Valley St. 424
Providence, RI 02909
USA
Providence, RI 02909
USA
Phone
Website
Email Address
Company Background Information
Overview
Incorporated in 2017 and based in both Providence, RI and New York City, EpiVax Oncology Inc. is a spin-out of EpiVax Inc. EpiVax Oncology leverages EpiVax's world class excellence in computational-immunology, genomics and vaccine design, built over the last 20 years.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/14/2018
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gad Berdugo
Chief Technical Officer
Dominique Bridon
President
Anne De Groot
VP - R & D
Michael Princiotta
Company Investors
- Morningside Group
- NextWaveBio
- Horatio Ventures NYC
- Accelerate New York Seed Fund
Browse more funded tech companies:
EpiVario | EPIX Pharmaceuticals
Share this article
About Our VC Deals Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs